top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Agents : Design, Synthesis and Evaluation
Anticancer Agents : Design, Synthesis and Evaluation
Autore Chen Qiao-Hong
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (606 p.)
Soggetto topico Medicine
Soggetto non controllato benzofurans
chemical synthesis
cytotoxic properties
HeLa
MOLT-4
K562
anticancer
anti-neuroinflammation
coumarin
dihydroartemisinin
flavonoids
allene
E-stereoselective
regioselective
anti-cancer activity
cyanopyridone
substituted pyridine
pyridotriazine
pyrazolopyridine
thioxotriazopyridine
anticancer activity
HepG2
antitumor activity
computational docking
MDM2-p53 interaction
xanthones
yeast-based assays
estrone derivatives
hydrazine
N-substituted pyrazoline
anti-ovarian cancer
topoisomerase II inhibitor
kinase inhibitor
antiproliferative agent
urea
synthesis
antiproliferative activity
apoptosis
indoleamine 2,3-dioxygenase
inhibitor
anti-tumor
immune modulation
tryptophan metabolism
taxoids
βIII-tubulin
P-glycoprotein
drug resistance
thiopene
thienopyrimidinone
thiazolidinone
breast cancer
benzofuran–pyrazole
nanoparticles
cytotoxic activity
PARP-1 inhibition
3,6-dibromocarbazole
5-bromoindole
carbazole
actin
migration
Thienopyrimidine
Pyrazole
PI3Kα inhibitor
quinazolin-4(3H)-one
quinazolin-4(3H)-thione
Schiff base
antioxidant activity
DFT study
ortho-quinones
beta-lapachone
tanshione IIA
PI3Ks
PI3Kδ inhibitors
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
anticancer agents
protein–protein interactions
virtual screening
mimetics
drug discovery
bivalency
polyvalency
antitumor
cell cycle
ovarian cancer
P-MAPA
IL-12
TLR signaling
inflammation
chemoresistance
4-(pyridin-4-yloxy)benzamide
1,2,3-triazole
c-Met
natural product
anticancer agent
zampanolide
Talazoparib
PARP inhibitor
prodrug
o-nitro-benzyl
photoactivatable protecting groups
salinomycin
overcoming drug resistance
tumor specificity
synergy
5-fluorouracil
gemcitabine
amides/esters
colchicine analogs
thiocolchicine
colchiceine
antimitotic agents
hydrates
dihydropyranoindole
HDAC inhibitors
neuroblastoma
aromatase
MCF-7
NIH3T3
benzimidazole
triazolothiadiazine
docking
ADME
organosilicon compounds
SILA-409 (Alis-409)
SILA-421 (Alis-421)
multidrug resistance (MDR) reversal
ABCB1 (P-glycoprotein)
colon cancer
colchicine amide
colchicine sulfonamide
tubulin inhibitors
docking studies
crystal structure
PROTACs
protein degradation
IGF-1R
Src
protein kinase
phenylpyrazolopyrimidine
enzyme inhibition
molecular simulation
androgen receptor
prostate cancer
enzalutamide
apalutamide
darolutamide
triple-negative breast cancer
cytotoxicity
chrysin analogues
flavonoid
anticancer compounds
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anticancer Agents
Record Nr. UNINA-9910557129103321
Chen Qiao-Hong  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Autore Alix-Panabieres Catherine
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (366 p.)
Soggetto non controllato FOLFIRINOX
immunofluorescence imaging
AR-V7
circulating tumour cells
chemoradioresistance
CTC-based treatment decisions
rVAR2
immunophenotyping
immune system
CellSearch®
flow cytometry
clinical trials
circulating tumor DNA
synaptophysin
stem cells
colorectal cancer
melanoma
CTC biology
platelets
AR
CTC capture technology
castration resistant prostate cancer (CRPC)
PD-L1 expression
rovalpituzumab tesirine
HMB-45
thymidylate synthase
ctDNA
tumor cell dissemination
solid cancers
metastasis
locally advanced rectal cancer
miRNA
epithelial-to-mesenchymal transition (EMT)
NSCLC
tumor biomarkers
tumor stem cells
circulating tumor cells
major histocompatibility complex class I (MHCI)
bone marrow
heterogeneity
cerebrospinal liquid biopsy
fish
glioma
in vivo flow cytometry
colorectal surgery
CellSearch
single-cell analysis
disseminated tumor cells
EasyCount slides
microsatellite instability
circulating plasma cells
circulating leukemia cells
ARV7
SLUG
androgen receptor
metastatic colorectal cancer
leukocyte-derived extracellular vesicles
prostate cancer (PCa)
neutrophils
liquid biopsy
enzalutamide
CD133
enrichment and detection technologies
biomarkers
immune checkpoint inhibitors
biomarker
RAD23B
microbiome
integrin B1
ACCEPT
emboli
small-cell lung carcinoma
EPISPOT
microfluidics
early breast cancer
circulating tumor cells (CTC)
tumor-initiating cells (TICs)
immunomodulation
xenograft models
CTC-derived xenografts
malaria
circulating tumor cells (CTCs)
clinical utility
exosomes
liquid surgery
ctRNA
CTCs
epithelial-mesenchymal transition
targeted therapy
hematological cells
gene expression analysis
hepatocellular carcinoma (HCC)
breast cancer
EpCAM enrichment
prostate cancer
CTC
abiraterone
fibronectin
CTC-derived ex vivo models
CTMat
chromogranin A
CTM
exosome
ISBN 3-03928-699-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Circulating Tumor Cells
Record Nr. UNINA-9910404091403321
Alix-Panabieres Catherine  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cytobiology of Human Prostate Cancer Cells and Its Clinical Applications
Cytobiology of Human Prostate Cancer Cells and Its Clinical Applications
Autore Ishii Kenichiro
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (184 p.)
Soggetto topico Medicine
Soggetto non controllato androgen receptor
docetaxel
cabazitaxel
castration-resistant prostate cancer
chemotherapy
P-glycoprotein
EPI-002
splice variant
prostate-specific antigen
androgen deprivation therapy
time to PSA nadir
fibroblasts
prostate cancer
androgen sensitivity
pirfenidone
TGFβ1
G1 cell cycle arrest
fibroblast growth factor
fibroblast growth factor receptor
obesity
inflammation
immune cells
cytokine
high-fat diet
KIFC1
docetaxel resistance
apoptosis
CW069
Caveolin-1
TP53-regulated inhibitor of apoptosis 1
tumour stroma
tumour microenvironment
fibroblast
CAF
resistance
radiotherapy
CCL2
CCL22
CCL5
migration
LSD1
epigenetics
autophagy
abiraterone
enzalutamide
testosterone
castration resistant prostate cancer
animal model
diet
fat
in vitro
in vivo
mouse
AKR1C3
hormone-naïve prostate cancer
immunohistochemistry
tissue microarray
androgen receptor dependency
fibroblast-dependent androgen receptor activation
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557116703321
Ishii Kenichiro  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Free Radical Research in Cancer
Free Radical Research in Cancer
Autore Čipak Gašparović Ana
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (192 p.)
Soggetto topico Technology: general issues
Soggetto non controllato NQO1
NQO1*2
polymorphism
quinone
breast cancer
menadione
lapachone
doxorubicin
ascorbate
oxidative stress
reactive oxygen species
sperm
cancer chemotherapy
antioxidant therapy
antioxidant proteins
chemoresistance
oxaliplatin
5-Fluorouracil
myelodysplastic syndromes
carbonylation
deferasirox
ovary
calcium channel
Trolox
granulosa cell tumor
cell death
mitochondria
photodynamic therapy
singlet oxygen
nitric oxide
light
combination therapy
antioxidants
bleomycin
cancer treatment
chemotherapy-induced toxicity
cisplatin
free radicals
methotrexate
ozone therapy
lung cancer
cancer metabolism
reactive oxygen species (ROS)
therapy resistance
new therapeutic strategies
breast cancer stem cells
4-hydroxy-2-nonenal
extracellular matrix
NRF2
bardoxolone methyl
prostate cancer
castration-resistant prostate cancer
androgen receptor (AR), AR-V7
anti-androgen
enzalutamide
androgen deprivation therapy
cancer
antioxidant
triphala
ayurveda
chemoprevention and chemotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557152603321
Čipak Gašparović Ana  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Urological Cancer 2021
Urological Cancer 2021
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (328 pages)
Soggetto topico Research
Chemistry
Soggetto non controllato bladder cancer
radiotherapy
radiosensitisation
molecular subtypes
preclinical studies
bladder cancer cell lines
latent cancer
prostate cancer
autopsy
prognostic index
prediction model
mortality
screening trial
renal cell carcinoma
PD-1
PD-L1
biomarkers
immune checkpoint inhibitors
prostatic neoplasms
positron-emission tomography
decision making
tumor thrombus
metastasectomy
postoperative complications
oncological outcomes
radical cystectomy
AHNAK2
prognosis
dog
comparative oncology
inflammation
prostatic atrophy
preneoplastic lesion
biomarker
urine
machine learning
TRIPOD
liquid biopsy
glutaminase
immunohistochemistry
in situ methods
prostate
PSMA-RLT
177Lu-PSMA
PSA
mCRPC
urinary bladder neoplasms
Bacillus Calmette-Guérin (BCG)
immunotherapy
divergent differentiation
variant morphology
survival
stereotactic body radiotherapy
frail patients
cancer
metastasis
genomic analysis
microenvironment
tumor ecology
game theory
fluorescence confocal microscopy
prostate biopsy
ablation margins
focal therapy
sphingosine 1-phosphate receptor 1
bladder carcinoma
cell migration
epithelial-mesenchymal transition
FTY-720
OIP5
papillary renal cell carcinoma
PLK1
tumorigenesis
therapy
image-guided
magnetic resonance imaging
ultrasonography
biopsy
abiraterone
enzalutamide
docetaxel
novel hormonal therapies
comparative effectiveness
real-world treatment pattern
metastatic prostate cancer
epiplakin
diagnosis
advanced urothelial carcinoma
immune checkpoint inhibitor
prognostic
tumour mutational board
genomic signatures
ctDNA
inflammatory indices
urothelial carcinoma
frailty
prognostic factor
psoas muscle
Hounsfield units
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576872803321
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui